Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs-Reference-Cited by-同舟云学术

Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs

Published:2022-05-12 Issue:1 Volume:31 Page:80-90
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

A. Elrayess Mohamed¹,T. Zedan Hadeel¹²,A. Alattar Rand³,Abusriwil Hatem⁴,Al-Ruweidi Mahmoud Khatib A. A.¹,Almuraikhy Shamma¹,Parengal Jabeed³⁵,Alhariri Bassem⁴,Yassine Hadi M.¹,A. Hssain Ali⁶,Nair Arun³⁵,Al Samawi Musaed³⁵,Abdelmajid Alaaeldin³⁵,Al Suwaidi Jassim⁷,Omar Saad Mohamed⁸,Al-Maslamani Muna³⁵,Omrani Ali S.³⁵^ORCID,Yalcin Huseyin C.¹

Affiliation:

1. Biomedical Research Center, Qatar University, Doha, Qatar

2. Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar

3. Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar

4. Department of Internal Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar

5. Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar

6. Medical Intensive Care Unit, Hamad Medical Corporation, Doha, Qatar

7. Department of Cardiology, Hamad Medical Corporation, Doha, Qatar

8. Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar

Funder

Qatar National Research Fund

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/08037051.2022.2055530

Reference58 articles.

1. Severe covid-19 pneumonia: pathogenesis and clinical management

2. Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

3. COVID-19, ACE2, and the cardiovascular consequences

4. ACE2 and COVID-19 and the resulting ARDS

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional Self-Signaling nanoMIP and Its Application for a Washing-Free Assay of Human Angiotensin-Converting Enzyme 2;Analytical Chemistry;2024-04-26

2. The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic;Microorganisms;2024-03-14

3. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review;Vaccines;2023-01-17

4. Therapeutic Potential of Selected Medicinal Plants for Neurological Disorders after the Infection of COVID-19;Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products;2023

5. Circulating angiotensin converting enzyme 2 and COVID-19;World Journal of Clinical Cases;2022-12-06